Provision of Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services – (Intracranial) All Ages, All Indications including Paediatric Neuro-Oncology SRS/SRT Services
A Tender Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- 7 year
- Value
- £84M
- Sector
- HEALTH
- Published
- 12 Jan 2024
- Delivery
- 01 Oct 2024 to 30 Sep 2031
- Deadline
- 23 Feb 2024 12:00
Concepts
Location
Leeds
2 buyers
- NHS England Leeds
Description
NHS Arden and Greater East Midlands Commissioning Support unit on behalf of NHSEngland wish to procure under Lots four All Tiers Stereotactic Radiosurgery / Radiotherapy(SRS /SRT) Services – (Intracranial) all ages, including paediatric oncology services coveringEngland.SRS/SRT are methods of delivering doses of precisely targeted intracranial radiotherapytreatment and used for a wide range of malignant and benign intracranial conditions, as setoutwithin NHS England clinical commissioning policy. This comprises Tier 1-2 indications ofcerebral metastases, non-skull base meningiomas, skull base tumours including VestibularSchwannoma and meningioma, pituitary adenoma, and the Tier 3-4 indications includingarteriovenous malformations, trigeminal neuralgia and paediatric CNS tumours. Theprevalence of these conditions varies from less than one per 100,000 population to up to 30per 100,000.The two Service Specification include a tiered service model, based on clinical indicationprevalence and complexity and groups together more common, less complex conditions(called Tier 1&2) and less common and more complex conditions (called Tier 3&4).The two service specification, cover:(i) Tier 1 & 2 indications for adults; and(ii) All tiers, all ages and all conditions as this better reflects service provision and pathways.This procurement is focused on the ALL Tiers, all ages Service Specification ONLY.The Lots will cover the whole of England based on the following Geographies:1. Lot 1: North England and North West England2. Lot 2: South Yorkshire and Midlands3. Lot 3: Greater London, East of England and South England4. Lot 4: South West of England The objective of this procurement is to commission four Lots All Tiers Stereotactic Radiosurgery / Radiotherapy (SRS /SRT) Services – (Intracranial) all ages, including paediatric oncology services covering England. The eligibility criteria, lotting structure and scope of services are detailed in this document. Bidders must be located within the Lot geography for which they are bidding. Bidders are only required to deliver the Tier 1 and 2 services within the geographical catchment area served by the neurosurgical service in which they are based and not for the whole Lot geography.On completion of the procurement process, NHS England will complete a Market Engagement exercise scheduled, to follow the outcome from this procurement process for the remaining Tier 1 & Tier 2 services which will be open to all bidders.In order to be eligible, bidders must ensure that:a) The Service is delivered as part of an integrated neurosurgical and oncology service located within the same geographical area or city serving a population of at least 2 million in order to generate 100 SRS/SRT Tier 1&2 cases per year.b) The Service is delivered as part of an integrated paediatric neurosurgical and oncology service, commissioned to provide Paediatric Photon Radiotherapy located within the same geographical area or city to a Children’s Cancer Principal Treatment Centre (PTC)c) The neurosurgical centre must host the full range of specialist intracranial Multi-disciplinary Teams (MDT) for all clinical indications for adult and paediatric intracranial tumours, namely, combined Neurosciences Brain and Central Nervous System (CNS) MDT, and / or the individual neuro-oncology MDTs, skull base MDT, and pituitary MDT, neuro-vascular MDT and Paediatric oncology MDTs as listed in Table 1.2.d) The Service must deliver the complete range of SRS/SRT treatments including paediatric oncology indications (Table 1.2) and participate in the full range of specialist neurosurgical MDTs and generate a minimum annual activity volume of: (i) 100 SRS/SRT Tier 1 and Tier 2 cases; plus (ii) circa 200 Tier 3 and Tier 4 (combined) cases.SRS/SRT are methods of delivering doses of precisely targeted intracranial radiotherapy treatment and used for a wide range of malignant and benign intracranial conditions, as set-out within NHS England clinical commissioning policy. This comprises Tier 1-2 indications of cerebral metastases, non-skull base meningiomas, skull base tumours including Vestibular Schwannoma and meningioma, pituitary adenoma, and the Tier 3-4 indications including arteriovenous malformations, trigeminal neuralgia and paediatric CNS tumours. The prevalence of these conditions varies from less than one per 100,000 population to up to 30 per 100,000. This tiered service model is based on clinical indication prevalence and complexity and groups together more common, less complex conditions (called Tier 1&2) and less common and more complex conditions (called Tier 3&4).The two service specifications, cover: (i) Tier 1 & 2 indications for adults; and (ii) All tiers, all ages and all conditions as this better reflects service provision and pathways.This procurement is focused on the ALL Tiers, all ages Service Specification ONLY.The Lots will cover the whole of England based on the following Geographies:1. Lot 1: North England and North West England2. Lot 2: South Yorkshire and Midlands3. Lot 3: Greater London, East of England and South England4. Lot 4: South West of England
Lot Division
1 | North England and North West England
|
2 | South Yorkshire and Midlands
|
3 | Greater London, East of England and South England
|
4 | South West of England
|
CPV Codes
- 85100000 - Health services
Indicators
- Bids should cover one or more lots.
- Bids should cover the whole contract.
- Renewals are not available.
- Award on basis of price and quality.
Reference
- FTS 001167-2024